載入...
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Histone demethylase LSD1 plays key roles during carcinogenesis, targeting LSD1 is becoming an emerging option for the treatment of cancers. Numerous LSD1 inhibitors have been reported to date, some of them such as TCP, ORY-1001, GSK-2879552, IMG-7289, INCB059872, CC-90011, and ORY-2001 currently und...
Na minha lista:
| 發表在: | J Hematol Oncol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894138/ https://ncbi.nlm.nih.gov/pubmed/31801559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0811-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|